Sunday, June 20, 2021

    Egypt’s Eva Pharma to export COVID-19 drug remdesivir to India

    Must read

    Naija247news Media, New York
    Naija247news is an investigative news platform that tracks news on Nigerian Economy, Business, Politics, Financial and Africa and Global Economy.

    Egypt’s Eva Pharma on Monday signed an agreement to provide India with 300,000 doses of remdesivir, used in the treatment of COVID-19, the company said in a statement.

    The agreement, which was signed at the Indian embassy in Cairo, is aimed at helping India combat a surge in infections which has overwhelmed the health system and held close to record daily highs on Monday. read more

    Eva Pharma, a generic drugmaker established in 1997, said in June 2020 it had received a licence from Gilead Sciences Inc (GILD.O) to make remdesivir in Egypt and distribute it in 127 countries.

    The drug targets moderate to severe cases of COVID-19 in intensive care who require oxygen.

    Eva Pharma didn’t disclose the deal’s value.

    - Advertisement -spot_img

    More articles

    - Advertisement -spot_img

    Latest article

    WP to LinkedIn Auto Publish Powered By :